Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation.
Authors:
Journal: Nature communications
Publication Type: Journal Article
Date: 2020
DOI: PMC7453018
ID: 32855397
Abstract
Older organs represent an untapped potential to close the gap between demand and supply in organ transplantation but are associated with age-specific responses to injury and increased immunogenicity, thereby aggravating transplant outcomes. Here we show that cell-free mitochondrial DNA (cf-mt-DNA) released by senescent cells accumulates with aging and augments immunogenicity. Ischemia reperfusion injury induces a systemic increase of cf-mt-DNA that promotes dendritic cell-mediated, age-specific inflammatory responses. Comparable events are observed clinically, with the levels of cf-mt-DNA elevated in older deceased organ donors, and with the isolated cf-mt-DNA capable of activating human dendritic cells. In experimental models, treatment of old donor animals with senolytics clear senescent cells and diminish cf-mt-DNA release, thereby dampening age-specific immune responses and prolonging the survival of old cardiac allografts comparable to young donor organs. Collectively, we identify accumulating cf-mt-DNA as a key factor in inflamm-aging and present senolytics as a potential approach to improve transplant outcomes and availability.
Chemical List
- Cell-Free Nucleic Acids|||Cytokines|||DNA, Mitochondrial|||Quercetin|||Dasatinib
Reference List
- Korolchuk VI, Miwa S, Carroll B, von Zglinicki T. Mitochondria in cell senescence: is mitophagy the weakest link? EBioMedicine. 2017;21:7–13.|||Tullius SG, Rabb H. Improving the supply and quality of deceased-donor organs for transplantation. N. Engl. J. Med. 2018;378:1920–1929.|||Klassen DK, et al. The OPTN deceased donor potential study: implications for policy and practice. Am. J. Transpl. 2016;16:1707–1714.|||Tullius SG, Milford E. Kidney allocation and the aging immune response. N. Engl. J. Med. 2011;364:1369–1370.|||Oberhuber R, et al. CD11c+ dendritic cells accelerate the rejection of older cardiac transplants via interleukin-17A. Circulation. 2015;132:122–131.|||Tullius SG, et al. Contribution of prolonged ischemia and donor age to chronic renal allograft dysfunction. J. Am. Soc. Nephrol. 2000;11:1317–1324.|||Krishnamurthy J, et al. Ink4a/Arf expression is a biomarker of aging. J. Clin. Investig. 2004;114:1299–1307.|||Franceschi C, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244–254.|||Kirkland, J. L. & Tchkonia T. Cellular senescence: a translational perspective. EBioMedicine21, 21–28 (2017).|||Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J. Clin. Investig. 2013;123:966–972.|||Xu, M. et al. Senolytics improve physical function and increase lifespan in old age. Nat. Med. 24, 1246–1256 (2018).|||Freund A, Orjalo AV, Desprez PY, Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010;16:238–246.|||Valentijn FA, Falke LL, Nguyen TQ, Goldschmeding R. Cellular senescence in the aging and diseased kidney. J. Cell Commun. Signal. 2018;12:69–82.|||Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479:232–236.|||Anderson, R. et al. Length-independent telomere damage drives post-mitotic cardiomyocyte senescence. Embo J. 38, 10.15252/embj.2018100492 (2019).|||Pinti M, et al. Circulating mitochondrial DNA increases with age and is a familiar trait: Implications for “inflamm-aging”. Eur. J. Immunol. 2014;44:1552–1562.|||Zhang Q, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104–107.|||Oka T, et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485:251–255.|||Tsuji N, et al. Role of mitochondrial DNA in septic AKI via toll-like receptor 9. J. Am. Soc. Nephrol. 2016;27:2009–2020.|||Hu Q, Wood CR, Cimen S, Venkatachalam AB, Alwayn IP. Mitochondrial damage-associated molecular patterns (MTDs) are released during hepatic ischemia reperfusion and induce inflammatory responses. PLoS ONE. 2015;10:e0140105.|||Wang L, et al. Plasma nuclear and mitochondrial DNA levels in acute myocardial infarction patients. Coron. Artery Dis. 2015;26:296–300.|||Pollara, J., Edwards, R. W., Lin, L., Bendersky, V. A., Brennan, T. V. Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction. JCI Insight. 3, 10.1172/jci.insight.121622 (2018).|||Scozzi D, et al. Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction. Am. J. Transpl. 2019;19:1464–1477.|||Zhang Q, Itagaki K, Hauser CJ. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock. 2010;34:55–59.|||Xu X, et al. Aging aggravates long-term renal ischemia-reperfusion injury in a rat model. J. Surg. Res. 2014;187:289–296.|||Fan Q, et al. Aging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and rats. Age. 2013;35:1017–1026.|||Lucas DT, Szweda LI. Cardiac reperfusion injury: aging, lipid peroxidation, and mitochondrial dysfunction. Proc. Natl Acad. Sci. USA. 1998;95:510–514.|||Agrawal A, Agrawal S, Gupta S. Role of dendritic cells in inflammation and loss of tolerance in the elderly. Front Immunol. 2017;8:896.|||Zhu Y, et al. The Achilles’ heel of senescent cells: From transcriptome to senolytic drugs. Aging Cell. 2015;14:644–658.|||Nowak EC, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J. Exp. Med. 2009;206:1653–1660.|||Schmitt V, Rink L, Uciechowski P. The Th17/Treg balance is disturbed during aging. Exp. Gerontol. 2013;48:1379–1386.|||Tomihara K, et al. Aging-associated B7-DC+ B cells enhance anti-tumor immunity via Th1 and Th17 induction. Aging Cell. 2012;11:128–138.|||Min WP, et al. Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival. J. Immunol. 2000;164:161–167.|||Sanada F, et al. Source of chronic inflammation in aging. Front. Cardiovasc. Med. 2018;5:12.|||Franceschi C, Garagnani P, Vitale G, Capri M, Salvioli S. Inflammaging and ‘Garb-aging’. Trends Endocrinol. Metab. 2017;28:199–212.|||Hu Q, Zhou Q, Wu J, Wu X, Ren J. The role of mitochondrial DNA in the development of ischemia reperfusion injury. Shock. 2019;51:52–59.|||van der Bliek AM, Sedensky MM, Morgan PG. Cell biology of the mitochondrion. Genetics. 2017;207:843–871.|||Linnane AW, Marzuki S, Ozawa T, Tanaka M. Mitochondrial DNA mutations as an important contributor to ageing and degenerative diseases. Lancet. 1989;1:642–645.|||Wallace DC, Mitochondrial DNA. mutations in disease and aging. Environ. Mol. Mutagen. 2010;51:440–450.|||Wang W, Yang X, Lopez de Silanes I, Carling D, Gorospe M. Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J. Biol. Chem. 2003;278:27016–27023.|||Moiseeva O, Bourdeau V, Roux A, Deschenes-Simard X, Ferbeyre G. Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol. Cell Biol. 2009;29:4495–4507.|||Passos JF, et al. Feedback between p21 and reactive oxygen production is necessary for cell senescence. Mol. Syst. Biol. 2010;6:347.|||Wiley CD, et al. Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. 2016;23:303–314.|||Dimri GP, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA. 1995;92:9363–9367.|||Pathak S, et al. Polymeric microsphere-facilitated site-specific delivery of quercetin prevents senescence of pancreatic islets in vivo and improves transplantation outcomes in mouse model of diabetes. Acta Biomater. 2018;75:287–299.|||Correia-Melo C, et al. Mitochondria are required for pro-ageing features of the senescent phenotype. EMBO J. 2016;35:724–742.|||Shimada K, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36:401–414.|||Ren J, Zhang Y. Targeting autophagy in aging and aging-related cardiovascular diseases. Trends Pharm. Sci. 2018;39:1064–1076.|||Agrawal A, Tay J, Ton S, Agrawal S, Gupta S. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J. Immunol. 2009;182:1138–1145.|||Torralba D, et al. Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts. Nat. Commun. 2018;9:2658.|||Ingelsson B, et al. Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C. Proc. Natl Acad. Sci. USA. 2018;115:E478–E487.|||Yousefi S, et al. Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med. 2008;14:949–953.|||Agrawal A, et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 2007;178:6912–6922.|||Roos, C. M. et al. Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell, 10.1111/acel.12458 (2016).|||Palmer, A. K. et al. Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell. 18, e12950 (2019).|||Moncsek, A. et al. Targeting senescent cholangiocytes and activated fibroblasts with Bcl-xL inhibitors ameliorates fibrosis in Mdr2-/- mice. Hepatology67, 247–259 (2017).|||Musi N, et al. Tau protein aggregation is associated with cellular senescence in the brain. Aging Cell. 2018;17:e12840.|||Ogrodnik M, et al. Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun. 2017;8:15691.|||Tesar BM, et al. Murine [corrected] myeloid dendritic cell-dependent toll-like receptor immunity is preserved with aging. Aging Cell. 2006;5:473–486.|||Stout-Delgado HW, Yang X, Walker WE, Tesar BM, Goldstein DR. Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J. Immunol. 2008;181:6747–6756.|||Justice JN, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554–563.|||Martyanov, V., Whitfield, M. L. & Varga, J. Senescence signature in skin biopsies from systemic sclerosis patients treated with senolytic therapy: potential predictor of clinical response? Arthritis Rheumatol. 71, 1766–1767 (2019).|||Hickson LJ, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446–456.|||Kandhaya-Pillai R, et al. TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion. Aging. 2017;9:2411–2435.|||Braumuller H, et al. T-helper-1-cell cytokines drive cancer into senescence. Nature. 2013;494:361–365.|||Kim KS, Kang KW, Seu YB, Baek SH, Kim JR. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells. Mech. Ageing Dev. 2009;130:179–188.|||Jurk D, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun. 2014;2:4172.|||Ciaramella A, et al. Myeloid dendritic cells are decreased in peripheral blood of Alzheimer’s disease patients in association with disease progression and severity of depressive symptoms. J. Neuroinflammation. 2016;13:18.|||Niemann CU, Malinoski D. Therapeutic hypothermia in deceased organ donors and kidney-graft function. N. Engl. J. Med. 2015;373:2687.